Evidence map›Paper›PMID 31131088›Full record

ReviewF1000Research2019

Recent advances in marburgvirus research.

Judith Olejnik, Elke Mühlberger, Adam J Hume

Abstract readReview
In one paragraph

Review in F1000Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Refining early detection of Marburg Virus Disease (MVD) in Rwanda: Leveraging predictive symptom clusters to enhance case definitions.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
    Article
  2. Marburg Virus Disease: A Narrative Review.Health science reports · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Marburg virus disease: A summary for clinicians.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Judith OlejnikDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, 02118, USA.
Elke MühlbergerDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, 02118, USA.
Adam J HumeDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, 02118, USA.ORCID 0000-0001-8454-3472

Funding

Regulatory Compliance CoreUC7AI095321 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROBERT A DAVEY · 2014 to 2026
$159.3M
Mechanisms of Marburg virus gene expressionR01AI133486 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FEARNS, RACHEL, MUHLBERGER, ELKE C · 2018 to 2022
$2.7M
The role of TLR4 signaling in the pathogenesis of filovirus infectionR21AI135912 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MUHLBERGER, ELKE C · 2018 to 2019
$454k
NIAID NIH HHS R01 AI133486NIAID NIH HHS R21 AI135912NIAID NIH HHS UC7 AI095321
6 · The paper itself

Abstract

Marburgviruses are closely related to ebolaviruses and cause a devastating disease in humans. In 2012, we published a comprehensive review of the first 45 years of research on marburgviruses and the disease they cause, ranging from molecular biology to ecology. Spurred in part by the deadly Ebola virus outbreak in West Africa in 2013-2016, research on all filoviruses has intensified. Not meant as an introduction to marburgviruses, this article instead provides a synopsis of recent progress in marburgvirus research with a particular focus on molecular biology, advances in animal modeling, and the use of Egyptian fruit bats in infection experiments.

Indexed as

ChiropteraAfrica, WesternAnimalsBiomedical ResearchDisease Models, AnimalDisease OutbreaksEbolavirusHumansMarburgvirusEgyptian rousettefilovirusfilovirusesMarburg virusmarburgvirusesviral proteins

Identifiers

PMID31131088
PMCPMC6530603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.